|
Featured Stories
|
|
|
|
Thursday, 21 Jan 2010
The US Food and Drug Administration has approved Thoratec’s PMA (pre-market approval) supplement, allowing the use of its HeartMate II left ventricular assist system for destination therapy. [more]
|
|
|
Monday, 11 Jan 2010
The everolimus-eluting stent, Xience V has been approved by the Japanese Ministry of Health, Labour and Welfare (MHLW), Abbott has announced. [more]
|
|
|
Wednesday, 23 Sep 2009
Mega has a smaller insertion point than traditional 50cc intra-aortic balloons and offers additional blood volume displacement for intra-aortic balloon counterpulsation. [more]
|
|
|
Monday, 21 Sep 2009
Boston Scientific announced on 21 September 2009 release of its CE-marked, next-generation iLab System Software for the iLab Ultrasound Imaging System. [more]
|
|
|
Monday, 21 Sep 2009
PLATINUM clinical programme will support US and Japanese approval of new everolimus-eluting coronary stent system. [more]
|
|
|
Monday, 21 Sep 2009
Valturna combines in a single pill valsartan, an angiotensin receptor blocker, with aliskiren, the only approved direct renin inhibitor. [more]
|
|
|
Tuesday, 15 Sep 2009
Company plans fourth-quarter launch for XIENCE V in China, the second-largest drug-eluting stent market in the Asia-Pacific region. [more]
|
|
|
Tuesday, 08 Sep 2009
The procedures with the new lower-profile Ascendra 2 transapical delivery system were conducted at the University of Leipzig Heart Centre, Germany. [more]
|
|
|
Tuesday, 08 Sep 2009
According to the company, Avantgarde represents the latest and most advanced drug-free technology for the treatment of cardiovascular disease. [more]
|
|
|
Monday, 24 Aug 2009
The clinical program for Xience V studied patients in the US, Canada, Europe, South Africa and Asia-Pacific, and demonstrated excellent long-term results. [more]
|
|
|
Thursday, 16 Jul 2009
At 38mm, it is the longest available drug-eluting stent and affords a more efficient treatment option for the estimated 8-10% of patients with long lesions. [more]
|
|
|
Monday, 13 Jul 2009
Daiichi Sankyo and Lilly’ Effient reduces thrombotic cardiovascular events in patients with acute coronary syndromes managed with percutaneous coronary intervention. [more]
|
|
|
Thursday, 02 Jul 2009
Approved to reduce the risk of cardiovascular hospitalization, Multaq will be launched this summer in the US by Sanofi-aventis. [more]
|
|
|
Wednesday, 06 May 2009
BioInvent International AB has announced that its therapeutic antibody product candidate has reached the primary endpoint in its phase I trial, and was safe and well tolerated. [more]
|
|
|
Friday, 01 May 2009
Innovations in decision support, quality CPR and information management solutions help reduce critical time to lifesaving treatment. [more]
|
|
|
Tuesday, 09 Jun 2009
CID has announced that it has successfully defended European Patent 1277449 against an opposition filed by Conor Medsystem on proprietary drug-eluting stent technology. [more]
|
|
|
Thursday, 23 Apr 2009
OrbusNeich bio-engineered R stent showed low rate of stent thrombosis in studies presented at the Angioplasty Summit TCT Asia Pacific 2009. [more]
|
|
|
Tuesday, 21 Apr 2009
AnalyST Accel and Current Accel provide new alerts and insight into cardiac conditions such as atrial fibrillation and ischaemia. [more]
|
|
|
Tuesday, 14 Apr 2009
The Design Zentrum Nordrhein-Westfalen has bestowed the red dot design award on the world’s smallest cardiopulmonary support system Cardiohelp. [more]
|
|
|
Wednesday, 01 Apr 2009
The new system combines the Driver bare metal stent, platform of the company’s coronary stents, with an improved delivery system. [more]
|
|
|
|
